DrugsData.org (was EcstasyData): Test Details : Result #19764

- All Test Results
- Test Details
- Advanced Search
- Overview
- How the project is funded

© Copyright 2001-2024 Erowid Center. DrugsData is a project of Erowid Center. All rights reserved.

By using this site you agree not to publish its images, data, results, or analysis of its results without written permission from Erowid Center. Permission is required before using data from DrugsData in any of these ways, including importing it into public or shared databases, software, or systems. This policy has been in place since 2001 in order to require cooperation and credit by researchers and app authors.

Your javascript is turned off. To remove this message, turn on javascript and accept the Terms of Use.

New Submissions Are Not Currently Being Accepted

Samples sent after April 10, 2024 will be put on hold.

Viewing desktop version: Switch to Mobile

Pink Powder (Tusi)

Sold as: 2C-B

ID: 19764

ID:	19764
Name:	Pink Powder
Other Names:	Tusi
HPLC:The HPLC Lab Test
2C-B 2C-B aka Bees Ketamine Ketamine aka Ketalar, Ketaset MDMA MDMA aka Ecstasy, E, X

Test Date:	Mar 25, 2024
Pub. Date:	Apr 24, 2024
Src Location:	Geneva, Switzerland
Submitter Loc:	Geneva, -- Switzerland
Color:	Red / Pink
Size:	-
Data Source:	SaferParty.ch
Tested by:	DIZ
Lab's ID:	SP:202404-27

Sold as: 2C-B

Expected to be: Not Specified

Lab comments:

Ketamine: 40.0 %
MDMA: 17.0 %
2C-B: 0.1 %

Caution

The European drug checking group that analyzed this sample issued a caution because it contains drugs other than the one it was represented as.

Analyzed by SaferParty / nuit blanche (Switzerland) in March 2024.

Send in a sample for testing

DrugsData tests all psychoactive drugs including ecstasy tablets, powders, research chemicals, novel pschoactive substances, and other drugs through our licensed laboratory. Ecstasy/Molly tablets cost $100. Recreational drug powder/crystal/blotter costs $100. Pharmaceuticals, supplements and all others cost $150 per analysis.

Learn more

Support DrugsData

Should the public have access to independent analysis of the products they consume?

The vast majority of analyses of over-the-counter, prescription, and recreational drugs are performed in secret with no independent oversite or review. No other historical record, free from politically-controlled agencies, is currently available in North America nor most other parts of the world.

DrugsData, a project of Erowid Center, needs the support of professionals, students, parents, individuals with means, and small foundations for a total yearly budget of around $120,000 USD. Erowid Center's general budget and the co-pays we require fund most of this cost.

Donate now

Search Lab Results by	Advanced Search